Extrait

Background and study aims Mild hypothermia (when body temperature drops below 35°C) has been shown to be protective in many situations in intensive care and this study aims to find out whether it could help patients with severe and cerebral malaria. This is a pilot (small scale) study. Who can participate? Patients admitted to intensive care with severe malaria can participate in this study. What does the study involve? All patients are cooled to between 32 and 34°C using a cooled salt solution injected through their veins, in addition to standard treatment. What are the possible benefits and risks of participating? This technique may reduce death or brain damage from severe malaria. Where is the study run from? This study is run from University College Hospital, London, UK and Chittagong Medical College, Chittagong, Bangladesh. When is the study starting and how long is it expected to run for? The study will start in May 2014 and run for one year. Who is funding the study? The study is funded by Oxford University, UK. Who is the main contact? Dr Brian Angus [email protected]

Critère d'inclusion

• Malaria

Liens

• ictrp
• isrctn